Clinical Overview

“R Wave Abnormal” is this dataset’s own telegraphic annotation rather than a diagnosis any clinician writes in a chart, and there is no single clinical entity called an abnormal R wave — so the first job of this page is to say what the label can and cannot be taken to mean. This project’s own SNOMED cross-check found that the code behind the RWAb label resolves to a generic R wave parent concept — a term that names the waveform and asserts no abnormality at all — rather than to any specific R wave finding. That means the label cannot be trusted to carry a precise meaning on its own, and this page is scoped instead to what the clinical literature actually recognizes and names: an abnormality of R wave progression across the precordial leads. [CLINICAL REVIEW NEEDED: the dataset’s own annotation boundary is undocumented. A strip carrying this label may have been annotated for poor progression, for a reversed pattern, or for a dominant R wave in V1, and nothing in the mapping distinguishes them.]

Normal R wave progression is one of the most ordinary things on a 12-lead tracing. Moving from V1 across to V6, each electrode faces progressively more left ventricular mass, so the R wave grows and the S wave shrinks. The lead where the two are equal — where the R/S ratio crosses 1 and the complex flips from mostly negative to mostly positive — is the transition zone, and it normally sits between V3 and V4 (Farkas, Internet Book of Critical Care, 2024). A useful way to hold this in mind is that the precordial leads are not six unrelated views but six samples of one continuous spatial rotation of the QRS loop; a three-dimensional reanalysis of the standard ECG makes exactly that argument, describing progression as a rotation that the six planar leads merely sample at intervals (Bermejo Valdés, Journal of Electrocardiology, 2025).

Poor R wave progression (PRWP) means the R wave fails to grow as expected, so the transition arrives late or not at all. Every published definition targets that idea, but they do not agree on how to measure it, and the difference matters when you are reading someone else’s report. The commonly taught bedside threshold is an R wave of 3 mm or less in V3 (LITFL Poor R Wave Progression, 2024). A stricter and arguably better formulation defines it by the transition itself — S greater than or equal to R still present in V4, meaning transition occurs after V4 — on the reasoning that a V3-amplitude rule alone will also capture generally low-voltage tracings that are not really mis-progressing (Farkas, 2024). Research cohorts add their own variants: a Finnish general-population study required an R wave amplitude of 0.3 mV or less in V3 together with an R wave in V2 no larger than the R wave in V3 (Schröder et al., Heart Rhythm, 2022), while a Multi-Ethnic Study of Atherosclerosis analysis prespecified an R wave in V3 of 3 mm or less with the R wave in V3 still larger than in V2, and tested the older Zema myocardial-infarction criterion (R in V3 of 1.5 mm or less, or R in lead I of 4.0 mm or less) as a separate sensitivity analysis (de Alencar and Morales, International Journal of Cardiology, 2026). A reversed pattern is the more extreme version of the same problem: amplitude falls where it should rise, with R waves in V2 and V3 larger than those in V4 through V6 (Lizzo and Shams, StatPearls, 2025).

The clinically important thing to understand is how weak this finding is as evidence of anterior infarction, because that is the reading it most often draws. A scoping review of the entire literature found only 20 studies, no high-quality diagnostic-accuracy studies at all, pervasive selection bias, and definitions and outcomes so heterogeneous across the prevalence and prognostic studies that the review called the resulting risk of bias alarming; its conclusion was that reliance on poor or reversed R wave progression for diagnosing anterior infarction “should be discouraged” until better evidence exists (de Alencar et al., Journal of Electrocardiology, 2024). A subsequent accuracy study tested the finding directly against cardiac magnetic resonance in 2,950 community participants and found it essentially blind to anterior scar: sensitivity 0.0% (95% CI 0.0-15.6) against a strict fibrosis reference and 5.3% (1.1-14.6) against a liberal one, with specificity 94.4% in both, and positive likelihood ratios of 0.00 and 0.95 — that is, the finding moved the probability of anterior fibrosis essentially not at all. The authors concluded it should not be used as a diagnostic marker of anterior myocardial fibrosis (de Alencar and Morales, International Journal of Cardiology, 2026).

Its prognostic value is a separate question from its diagnostic value, and the two strongest studies disagree. In 6,854 Finnish general-population subjects followed for a mean of 24.3 years, poor progression was present in 3.1% and was independently associated with sudden cardiac death (hazard ratio 2.13; 95% CI 1.34-3.39), cardiac death (HR 1.75; 1.35-2.15), and all-cause mortality (HR 1.29; 1.08-1.54); within the subgroup that already had coronary artery disease the association with cardiac mortality was stronger (HR 1.71; 1.19-2.46), and the association with sudden cardiac death reached significance only in that subgroup (HR 2.62; 1.38-4.98) (Schröder et al., 2022). A Multi-Ethnic Study of Atherosclerosis analysis of participants who were free of clinical cardiovascular disease at enrolment reported no significant association with all-cause mortality or major adverse cardiovascular events (Multi-Ethnic Study of Atherosclerosis outcomes analysis, medRxiv preprint, 2025). [CLINICAL REVIEW NEEDED: the two results are not necessarily contradictory — the cohorts differ in baseline coronary artery disease, which is exactly the variable the Finnish study found to matter — but the outcomes analysis is currently a preprint rather than a peer-reviewed publication, so the safe reading for a learner is that prognosis depends on the company the finding keeps, and that poor progression in a patient with known coronary disease deserves more attention than the same finding in a healthy screening ECG.]

The mirror-image problem is a dominant R wave in V1, where the transition has effectively arrived too early. This is not a milder version of the same finding but a different differential, and it is the one with genuinely urgent members. Right ventricular hypertrophy is defined in part by a dominant R wave in V1 greater than 7 mm tall or with an R/S ratio greater than 1, accompanied by right axis deviation of +110 degrees or more and a dominant S wave in V5 or V6 (LITFL Right Ventricular Hypertrophy, 2024). A left-sided accessory pathway in ventricular pre-excitation produces a positive delta wave in all precordial leads with an R/S ratio greater than 1 in V1, and the tall R waves with inverted T waves in V1-V3 that result can mimic right ventricular hypertrophy without any hypertrophy being present (LITFL, 2026). And a posterior-wall infarction shows up here as its own reciprocal: a tall, broad R wave (greater than 30 ms) with an R/S ratio greater than 1 in V2, horizontal ST depression in V1-V3, and upright anterior T waves (LITFL Posterior Myocardial Infarction, 2024; Lizzo and Shams, StatPearls, 2025). StatPearls reports that this triad of horizontal or flat ST depression, prominent positive QRS complexes in V1 or V2, and upright T waves carries a positive predictive value approaching 95% for acute posterior infarction (Lizzo and Shams, StatPearls, 2025). [CLINICAL REVIEW NEEDED: whether that pattern is best attributed to the posterior wall or to the basal lateral wall is unsettled between sources — the same dispute already flagged on this project’s Pathologic Q Wave page.]

Abnormal R wave progression produces no symptoms of its own. It is a morphology finding on a tracing, and whatever the patient feels comes from the process underneath it — nothing at all if the cause is electrode position, a normal variant, or an old scar; chest pain, dyspnea, diaphoresis, nausea or syncope if the cause is an acute coronary event; exertional breathlessness and fatigue if it is a cardiomyopathy or chronic lung disease.

Recognized causes fall into four groups. Technical: electrodes placed too high, or precordial leads transposed, both of which produce poor or reversed progression on a structurally normal heart (Farkas, 2024; LITFL Poor R Wave Progression, 2024). Ventricular disease: prior anteroseptal infarction, left ventricular hypertrophy, dilated cardiomyopathy, and right ventricular hypertrophy (LITFL Poor R Wave Progression, 2024; Farkas, 2024). Conduction and anatomy: left anterior hemiblock (Farkas, 2024), and dextrocardia, which classically gives absent precordial R wave progression with dominant S waves throughout (LITFL, 2021 — this one page falls just outside the five-year recency window, so it is corroborated here by two in-window case reports that both describe absent precordial R wave progression in dextrocardia: Ballesteros et al., Archive of Clinical Cases, 2025; Mesele et al., Clinical Medicine Insights, 2026). Right ventricular pressure loading: lung hyperinflation (Farkas, 2024), and acute pulmonary thromboembolism — in 170 patients with confirmed acute pulmonary embolism, poor progression was present in 49 and tricuspid regurgitation velocity was its only independent correlate (odds ratio 1.67; 95% CI 1.08-2.58), with an NT-proBNP at or above 200 pg/mL also associated in subgroup analysis (odds ratio 3.31; 1.37-7.99); notably, chamber dimensions were not, which the authors read as pressure overload showing on the ECG before it shows on the echocardiogram (Wu et al., BMC Cardiovascular Disorders, 2026). Poor progression is also, plainly, a normal variant in some people (LITFL Poor R Wave Progression, 2024).

Interpretation Guide

Key Features:

• Rate: not a defining feature — this is a QRS morphology finding superimposed on whatever rate accompanies it
• Rhythm: not a defining feature — it says nothing about where the impulse originates or how regular it is
• P waves: normally biphasic in V1 and upright in V2. A fully negative P wave in V1, or a biphasic or fully negative P wave in V2, is a direct clue that those electrodes are sitting too high — a common technical cause of artifactual poor progression (LITFL Misplacement of V1 and V2, 2024; LITFL Poor R Wave Progression, 2024). An inverted P wave in lead I with an upright P wave in aVR instead points to dextrocardia or arm-lead reversal (LITFL, 2021)
• PR interval: within normal limits unless pre-excitation is present. A PR interval under 120 ms with a QRS over 110 ms and a slurred delta-wave upstroke explains a dominant R wave in V1 without any hypertrophy or infarction (LITFL, 2026)
• QRS complex: the defining feature, and it is the sequence across V1 to V6 that matters, not any single complex. Normal transition sits between V3 and V4, where the R/S ratio crosses 1 (Farkas, 2024). Poor progression is reported when the transition has still not occurred by V4 (S greater than or equal to R in V4), or by the simpler bedside rule of an R wave of 3 mm or less in V3 (Farkas, 2024; LITFL Poor R Wave Progression, 2024). Reversed progression is amplitude actively falling where it should rise — R waves in V2 and V3 larger than those in V4 through V6 (Lizzo and Shams, StatPearls, 2025). At the opposite extreme, a dominant R wave in V1 above 7 mm or with an R/S ratio above 1 is one of the defining criteria for right ventricular hypertrophy (LITFL Right Ventricular Hypertrophy, 2024). Measure the QRS duration before going further: at or above 120 ms with an RSR’ pattern in V1, the question is a bundle branch block, not R wave progression
• ST segment: within normal limits for an isolated progression finding. Horizontal ST depression in V1-V3 alongside a tall broad R wave in V2 is the posterior-infarction pattern and is not an isolated finding (LITFL Posterior Myocardial Infarction, 2024; Lizzo and Shams, StatPearls, 2025)
• T waves: upright anterior T waves complete that posterior-infarction triad. Conversely, false T wave inversion in V2 is another product of high V1-V2 electrode placement, so read T wave changes and progression changes in the same breath before concluding either is real (LITFL Misplacement of V1 and V2, 2024; LITFL Posterior Myocardial Infarction, 2024; Lizzo and Shams, StatPearls, 2025)
• QT interval: not part of any R wave progression criterion and not independently affected by this finding
• Other findings: right axis deviation of +110 degrees or more with a dominant S wave in V5 or V6 supports right ventricular hypertrophy as the explanation (LITFL Right Ventricular Hypertrophy, 2024). Positive QRS complexes with upright P and T waves in aVR, global negativity in lead I, and absent precordial R wave progression together indicate dextrocardia (LITFL, 2021; Ballesteros et al., 2025; Mesele et al., 2026). Left anterior hemiblock is a recognized cause of poor progression in its own right (Farkas, 2024)

Two ECGs recorded with deliberate attention to electrode position settle more of these cases than any amount of staring at one tracing, and comparison with a prior ECG is what separates a fixed, long-standing pattern from a new one.

Key Leads

• Lead V3 – The lead nearly every published criterion measures, whether as 3 mm, as 0.3 mV, or as the 1.5 mm Zema threshold. An electrode misplaced here changes the answer without changing the patient (LITFL Poor R Wave Progression, 2024; Schröder et al., 2022; de Alencar and Morales, International Journal of Cardiology, 2026)
• Lead V4 – The transition lead. The definition that holds up best asks a single question about this lead: is the S wave still as large as or larger than the R wave? If so, the transition has happened too late (Farkas, 2024)
• Leads V1 and V2 – Where technical error does the most damage and where the mirror-image findings live. High placement here manufactures poor progression, false Q waves, an rSr’ pattern, and T wave inversion in V2 on a normal heart; a genuine dominant R wave here instead opens the right ventricular hypertrophy, pre-excitation, bundle branch block, and posterior-infarction differential (LITFL Misplacement of V1 and V2, 2024; LITFL Poor R Wave Progression, 2024; LITFL Right Ventricular Hypertrophy, 2024; LITFL Posterior Myocardial Infarction, 2024)
• Leads V4, V5 and V6 read against V2 and V3 – Reversed progression is only visible as a comparison across this span, since it is defined by the right precordial R waves exceeding the left precordial ones (Lizzo and Shams, StatPearls, 2025). A dominant S wave in V5 or V6 deeper than 7 mm additionally supports right ventricular hypertrophy (LITFL Right Ventricular Hypertrophy, 2024)
• Leads V7, V8 and V9 (posterior leads, not on the standard tracing) – When a dominant R wave in V2 comes with horizontal ST depression and upright T waves, these added leads answer the question the standard twelve cannot, and only 0.5 mm of ST elevation in a single one of them is required (LITFL Posterior Myocardial Infarction, 2024; Lizzo and Shams, StatPearls, 2025)

Differential Diagnosis

• Complete Right Bundle Branch Block (CRBBB) — the most common structural explanation for a tall R wave in V1. Distinguishing clue: measure the QRS first. A block gives a QRS at or above 120 ms with a notched RSR’ (“rabbit ears”) in V1 and a broad slurred terminal S wave in I, aVL, V5-V6; an R wave progression abnormality by itself does not widen the QRS. If the QRS is wide and notched, the finding belongs to the block, and progression criteria were not derived for that setting.
• Right Ventricle Hypertrophy (RVH) — the chamber explanation for an early transition. Distinguishing clue: RVH gives a single dominant R wave in V1 above 7 mm or with an R/S ratio above 1, with right axis deviation of +110 degrees or more, a dominant S wave in V5-V6, and a QRS under 120 ms — one tall deflection rather than the notched RSR’ of a block. Right ventricular hypertrophy also appears on the other side of this page: it is a recognized cause of poor progression as well, because it drags the whole transition rightward.
• Ventricular Preexcitation (VPE) — the impostor that mimics both hypertrophy and infarction. Distinguishing clue: a PR interval under 120 ms with a slurred delta wave at the very start of the QRS and a QRS over 110 ms. A left-sided accessory pathway gives a positive delta wave in every precordial lead and an R/S ratio above 1 in V1, which reads as right ventricular hypertrophy on the strip but is not.
• Abnormal Q Wave (AQW) — the finding most often confused with poor progression, and the reason the confusion matters. Distinguishing clue: a pathological Q wave is a discrete negative deflection meeting a duration or depth criterion in at least two contiguous leads, whereas poor progression is about the trend in R wave amplitude across the precordial sequence and may involve no abnormal Q wave at all. The two are not interchangeable evidence: a Q wave carries far more weight for prior infarction than poor progression does, which on direct testing against cardiac magnetic resonance detected essentially no anterior fibrosis (de Alencar and Morales, International Journal of Cardiology, 2026).
• Lower Voltage QRS In All Lead (LVQRSAL) — the finding an amplitude-only criterion will misclassify. Distinguishing clue: low voltage is a diffuse amplitude reduction meeting a limb-lead or precordial-lead threshold across a whole lead group, while a progression abnormality is regional and about sequence. This is precisely why the R-in-V3-of-3-mm rule is criticized: on a globally low-voltage tracing it will report poor progression when nothing about the transition is actually abnormal (Farkas, 2024).

Treatment Brief

Nothing here is treated. What a monitoring technician or nursing student owns is measuring the sequence correctly, ruling out the technical causes before the clinical ones, and refusing to let this finding carry more diagnostic weight than the evidence supports.

• Check electrode placement before anything else, and re-record if it is in doubt. V1 and V2 belong in the fourth intercostal space at the sternal borders; a negative P wave in V1, a biphasic or negative P wave in V2, a new rSr’ pattern, or new T wave inversion in V2 all point to electrodes sitting too high rather than to disease (LITFL Misplacement of V1 and V2, 2024).
• Say which criterion you applied and give the measured values. “Transition after V4” and “R wave 3 mm or less in V3” are not the same test, and research definitions differ again from both (Farkas, 2024; LITFL Poor R Wave Progression, 2024; Schröder et al., 2022).
• Do not report poor R wave progression as evidence of an anterior infarction. The best available accuracy data found it essentially blind to anterior scar on cardiac magnetic resonance, and a full scoping review concluded that using it to diagnose anterior infarction should be discouraged (de Alencar et al., Journal of Electrocardiology, 2024; de Alencar and Morales, International Journal of Cardiology, 2026).
• Treat a dominant R wave in V1 or V2 as a different and more urgent question than poor progression. If it comes with horizontal ST depression and upright T waves in V1-V3 in a symptomatic patient, escalate to the provider and ask about posterior leads — only 0.5 mm of ST elevation in V7-V9 is needed to make that diagnosis (LITFL Posterior Myocardial Infarction, 2024; Lizzo and Shams, StatPearls, 2025).
• Measure the QRS duration before reaching for a progression interpretation. At or above 120 ms, a bundle branch block explains the precordial morphology and the progression question is secondary.
• Compare against a prior ECG whenever one exists. A stable, unchanged progression pattern in an asymptomatic patient is a very different report from a new one.
• Note the patient’s context when you flag it. In someone with known coronary artery disease the finding carried a meaningfully increased risk of cardiac death and sudden cardiac death in long-term follow-up, so it is worth passing on rather than filing as incidental (Schröder et al., 2022).
• Consider the right heart when poor progression appears in a breathless patient. Chronic lung hyperinflation and acute pulmonary embolism both produce it, and in confirmed pulmonary embolism it tracked with echocardiographic evidence of right ventricular pressure loading rather than with chamber enlargement (Farkas, 2024; Wu et al., BMC Cardiovascular Disorders, 2026).